Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 7/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | BRPF1 | P55201 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29878389 | 1.00 | ALDH1A1 (0.53) | ALDH1A1HPGDPKMTSHRPOLB | |
| SCHEMBL30022934 | 0.85 | DDB1 (0.46) | ALDH1A1HPGDPKMTSHRPOLB | |
| SCHEMBL399737 | 0.85 | DDB1 (0.46) | ALDH1A1HPGDPKMTSHRPOLB | |
| SCHEMBL1025445 | 0.79 | PKM (0.58) | ALDH1A1HPGDPKMTSHRPOLB | |
| SCHEMBL16846965 | 0.79 | NPC1 (0.41) | ALDH1A1HPGDKDM4EBRPF1MEN1 | |
| SCHEMBL9437718 | 0.78 | ALDH1A1 (0.50) | ALDH1A1HPGDPKMTSHRPOLB | |
| SCHEMBL6348798 | 0.78 | ALDH1A1 (0.53) | ALDH1A1HPGDPKMTSHRPOLB | |
| SCHEMBL2308656 | 0.78 | PKM (0.59) | ALDH1A1HPGDPKMTSHRPOLB | |
| SCHEMBL5536572 | 0.78 | PKM (0.59) | ALDH1A1HPGDPKMTSHRPOLB | |
| SCHEMBL5539787 | 0.78 | MEN1 (0.59) | ALDH1A1HPGDPKMTSHRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113087922-A | Clover-shaped metal organic supermolecule and preparation method and application thereof | 广州大学 | 2021-07-09 | — | — | CN | claimed |
| US-12590066-B2 | Fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-03-31 | — | — | US | disclosed |
| WO-2025245484-A1 | FOXN1 ACTIVATORS | THYMOFOX INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| US-20240327393-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | Sironax Ltd. (KY) | 2024-10-03 | — | — | US | disclosed |
| CN-117999259-A | Iron death modulators, their preparation and use | 维泰瑞隆有限公司 | 2024-05-07 | — | — | CN | disclosed |
| US-20230295095-A1 | NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-09-21 | — | — | US | disclosed |
| CN-114671878-B | Substituted nitrogen-containing bicyclic compounds and uses thereof | 广东东阳光药业有限公司 | 2023-08-04 | — | — | CN | disclosed |
| EP-4169905-A1 | NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF | Korea Institute of Science and Technology (KR) | 2023-04-26 | — | — | EP | disclosed |
| CN-115867277-A | Novel fused heterocyclyl-carbohydrazone acyldinitrile compounds and use thereof | 韩国科学技术研究院 | 2023-03-28 | — | — | CN | disclosed |
| US-20220396553-A1 | NOVEL HYDRAZONE DERIVATIVE IN WHICH TERMINAL AMINE GROUP IS SUBSTITUTED WITH ARYL GROUP OR HETEROARYL GROUP, AND USE THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-12-15 | — | — | US | disclosed |
| US-20020016492-A1 | Process for preparing 3-hydroxymethyl-4-(aryl or heterocyclic)-cyclopentanones | MERCK SHARP & DOHME CORP. | 2002-02-07 | — | — | US | disclosed |
| EP-0775107-B1 | PREPARATION OF O-(2-HYDROXYALKYL) OXIMES | BASF AG (DE) | 1999-10-13 | — | — | EP | disclosed |
| US-5618964-A | Prodrug esters of phosphonosulfonate squalene synthetase inhibitors and method | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-04-08 | — | — | US | disclosed |
| CN-1015334-B | PREPARATION METHOD FOR DERIVERTIVES | PFIZER (PA) | 1992-01-29 | — | — | CN | disclosed |
| US-5036088-A | Enzyme inhibitors; cyclooxygenase, lipoxygenase | PFIZER INC. (US) | 1991-07-30 | — | — | US | disclosed |
| US-5006541-A | Antiallergy and antiinflammatory agents | PFIZER INC. (US) | 1991-04-09 | — | — | US | disclosed |
| US-4904685-A | Antiallergy and antiinflammatory agents | PFIZER INC. (US) | 1990-02-27 | — | — | US | disclosed |
| US-4835166-A | LIPOXYGENASE, CYCLOOXYGENASE INHIBITORS | PFIZER INC. (US) | 1989-05-30 | — | — | US | disclosed |
| CN-87104099-A | Anti-allergic and antiphlogistic medicament | — | 1988-02-10 | — | — | CN | disclosed |
| EP-0249407-A2 | Antiallergy and antiinflammatory agents | Pfizer Corporation (PA) | 1987-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240327393-A1 | FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF | AIFM2, GPX1, GPX4 | ALDH1A1 1306/4885HPGD 207/4885PKM 327/4885 |
| US-20020016492-A1 | Process for preparing 3-hydroxymethyl-4-(aryl or heterocyclic)-cyclopentanones | CCR1, CCR5, CCR6 | ALDH1A1 2952/4885HPGD 392/4885PKM 3418/4885 |
| US-12590066-B2 | Fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and use thereof | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, CLIC1 | ALDH1A1 592/4885HPGD 2277/4885PKM 3992/4885 |
| US-20230295095-A1 | NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF | CBR3, DBF4, DDT | ALDH1A1 1343/4885HPGD 938/4885PKM 3008/4885 |
| US-20220396553-A1 | NOVEL HYDRAZONE DERIVATIVE IN WHICH TERMINAL AMINE GROUP IS SUBSTITUTED WITH ARYL GROUP OR HETEROARYL GROUP, AND USE THEREOF | AANAT, NAT1, HNMT | ALDH1A1 402/4885HPGD 544/4885PKM 2433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.